ITMCTR2100005394
Not yet recruiting
未知
Multiple-center randomized controlled clinical study of electroacupuncture relieving primary dysmenorrhea
The First Affiliated Hospital ,University of South China0 sitesTBD
Conditionsprimary dysmenorrhea
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- primary dysmenorrhea
- Sponsor
- The First Affiliated Hospital ,University of South China
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Meet the diagnostic criteria of primary dysmenorrhea
- •(2\) Age ranged from 14 to 35 years old.
- •(3\) Basic rules of the menstrual cycle (28 ±, 7 days).
- •(4\) Designers who volunteered to participate in the clinical study signed an informed consent, did not have other treatment for dysmenorrhea within 1 month before the acupuncture treatment, and did not take NSAoidal anti\-inflammatory drugs and painkillers within the first 2 weeks of the electric needle.
- •(5\) Willing to cooperate with the treatment operation, examination and efficacy evaluation, and did not participate in other clinical experiments.
- •(6\) Average pain visual simulation score (VisualAnalogueScale, VAS) for 4cm.
- •(7\) Sign the informed consent form.
- •The above 7 simultaneous applicants can only be included in the test.
Exclusion Criteria
- •(1\) After examination, western medicine is diagnosed as a secondary dysmenorrhea caused by uterine fibroids, adenomysiosis, endometriosis, pelvic inflammation, internal foreign body, ovarian lesions and other organic lesions.
- •(2\) Menstrual period is successively irregular.
- •(3\) Patients with serious cardiovascular and cerebrovascular diseases, serious diabetes mellitus, serious infection, liver and renal insufficiency, hematopoietic diseases, AIDS, and tuberculosis, hepatitis and other infectious diseases.
- •(4\) People with obvious mental illness and obvious cognitive dysfunction.
- •(5\) Pregnancy or pregnancy, lactation and postpartum within 1 year.
- •(6\) Those who are participating in other clinical trials.
- •Note: Studies were excluded for any one of the above compliance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A multi-center, randomized controlled clinical study for Xiansen Decoction combined with radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinomaITMCTR1900002641The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Completed
Not Applicable
Randomized controlled clinical multi-center study to investigate effectiveness and safety of a Collagen Matrix 10808 for soft tissue volume augmentation after implant placement in single tooth gaps compared to autogenous connective tissue graftK08.1Loss of teeth due to accident, extraction or local periodontal diseaseDRKS00005944Geistlich Pharma AG88
Recruiting
Phase 4
A multi-center randomized controlled clinical study of HIFU combined with Guizhi Poria Capsule in sequential treatment of uterine fibroidsITMCTR2100005040Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Recruiting
Phase 1
A multicenter randomized controlled clinical study of Fuzheng Xiaoji pill in the treatment of metastatic pancreatic cancerPancreatic cancerITMCTR2000003298Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical study of Yinlai Decoction in the treatment of children with influenza (pulmonary and gastric heat accumulation syndrome)influenzaITMCTR2100005417Beijing University of Chinese Medicine